REG - Iofina PLC - Notice of AGM and Proposed Capital Reduction

IofinaAnnouncement

14/05/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250514:nRSN4999Ia&default-theme=true

RNS Number : 4999I  Iofina PLC  14 May 2025

14 May 2025

 

Iofina plc

("Iofina", the "Company" or the "Group")

(AIM: IOF)

 

Notice of AGM and Proposed Capital Reduction

 

Iofina plc, specialists in the exploration and production of iodine and
manufacturers of specialty chemical products, today announces that its 2025
Annual General Meeting ("AGM") will take place on Monday, 9 June 2025 at 3:00
p.m. (BST) at the offices of Canaccord Genuity, 88 Wood Street, London EC2V
7QR.

 

In addition to the routine business customarily undertaken at an annual
general meeting, the Company is asking shareholders to consider a specific
item of special business at the AGM, namely the Capital Reduction. If approved
the Capital Reduction would have the effect of creating distributable reserves
and, subject to the financial performance of the Company and the provisions
contained in the CA 2006, allow the Company to make distributions of profits
by way of dividend and/or to make purchases of its own shares.

 

In seeking approval of the Capital Reduction, the Company is not indicating
any commitment, and has no current intention, to declare dividends or to
purchase its own shares, but considers that the Capital Reduction would
position it more favourably to do so, as applicable, in the future.

 

The Capital Reduction is conditional on, inter alia, Shareholder approval at
the AGM and approval by the Court. Full information, including timetable and
action to be taken by Shareholders regarding the Capital Reduction are set out
in the circular accompanying the AGM Notice (the "AGM Circular").

 

Unless otherwise stated, defined terms in this announcement are the same as
those set out in the AGM Circular.

 

The AGM Circular and Notice of AGM is being posted to Shareholders and a copy
will be made available on the Company's website.

 

Enquiries:

Dr. Tom Becker

CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

Nomad & Broker:

Henry Fitzgerald-O'Connor/Harry Rees

Canaccord Genuity Limited

Tel: +44 (0)20 7523 8000

Media Contact:

Charles Goodwin/Shivantha Thambirajah/Zara McKinlay

Yellow Jersey PR Limited

Tel: +44 (0)7747 788 221/+44 (0)7983 521 488

About Iofina:
Iofina plc (AIM: IOF) is a vertically integrated company that specialises in
the production of Iodine and the manufacturing of specialty chemical products.
Iofina is the second largest producer of iodine in North America and operates
the manufacturing entities Iofina Resources and Iofina Chemical.

LEI: 213800QDMFYVRJYYTQ84

ISIN: GB00B2QL5C79

Iofina Resources

Iofina Resources develops, builds, owns, and operates iodine extraction plants
using Iofina's WET® IOsorb® technology. Iofina currently operates seven
producing IOsorb® plants in Oklahoma and is consistently using technology and
innovation to improve and expand its operations.

Iofina Chemical

Iofina Chemical has manufactured high-quality halogen speciality chemicals
derived from raw iodine, as well as non-iodine-based products. Iofina Chemical
celebrated its 40(th) anniversary in 2023 as a preeminent halogen-based
specialty chemicals company.

www.iofina.com (http://www.iofina.com)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOAFLFLVEFIVLIE